On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
The symposium is proposed to make awareness in the academic research community on how to achieve successful translation of research results. The seminar & workshop will bring together Key Industrial Players, End-Users, Entrepreneurs, Investors, Top-class Scientists, Engineers, Policy Makers and Representatives from the UK, European and International Authorities to discuss, network and establish the Strategy and Policy for boosting the rapidly evolving nanomedicine Industry. Nanomedicine revolutionizes applications in cancer diagnosis, smart therapy, Health Care. This symposium will focus on 1) Clinical nanomedicine current stage and future. 2) Industrial Translation 3) IPR, Patent and technology transfers.
Speakers:
1. Prof. Ali Khademhosseini, Chief Executive officer Terasaki Institute (Amazon Professor at Harvard Medical School (2005-2017). The Highly Cited Researcher in the field of Nanomedicine
2. Prof. Y. Shrike Zhang, Harvard Medical School, Brigham and Women’s Hospital, University of Harvard
3. Prof. Twan Lammers, Professor of Medicine, RWTH Aachen University, Germany, The Highly Cited Researcher in the field of Industrial Nanomedicine
4. Prof. Helen Townley, Medical Science Division, University of Oxford, Oxford UK
5. Dr. Tanveer Tabish, Radcliffe Department of Medicine, University of Oxford, Oxford UK, Fellow of the British Heart Foundation.
6. Dr. David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada at AstraZeneca
